Founded in 1993
  Year: 2013 | Volume: 21 | Issue: 3-4 | Pages: 109-114
Ljiljana Tadic Latinovic, Aleksandra Salapura Dugonjic, Živka Eri, Slavica Kneževic Ušaj, Milana Panjkovic, Ljiljana Amidžic, Ilija Baroš, Branislava Jakovljevic
  Background: The increased expression of MMPs in tumor cells is considered immportant for invasive tumor growth and metastatic potential. The aim of the study was to analyze the expression level of matrix metalloproteinase 9 (MMP-9) in tumor cells, estimate the prognostic value of MMP-9 expression, and correlate the MMP-9 expression to histopathological characteristics of the tumor and the disease stage.
Methods: In this study, 107 patients with operable lung adenocarcinoma were examined, including the information obtained in a five-year follow-up. The expression of MMP-9 was determined in paraffin-embedded tissue specimens by immunohistochemical analysis.
Results: The research was performed in the patients who underwent a surgery for the removal of lung adenocarcinoma. The patients were divided into three groups based on the stage of the disease: stage I - diagnosed 54 (50.46%) stage II - 30 (28.04%) and stage IIIA - 23 (21.50%) patients. In the total sample, MMP-9 positivity was established in 61 (57.01%) patients, while 46 (42.99%) patients were negative or slightly positive. MMP-9 expression was registered in the disease stage I group, established as positive or negative MMP-9 expression in 27 (50.00%) patients, respectively. In stage II disease group, 17 (56.67%) patients had MMP-9 positive tumors and 13 (43.33%) had MMP-9 negative tumors. In 17 (73.91%) patients of the stage IIIA group, MMP-9 positivity was confirmed in the tumor tissue, while 6 (26.09%) had negative or low MMP-9 expression in tumor cells. The log rank analysis showed a significant correlation of a poor survival, higher disease stage (p=0.022), and high MMP-9 expression in tumor cells (p=0.002).
Conclusion: The study showed that the positive expression of MMP-9 was present in a large number of patients with advanced disease stages. The patients with lung adenocarcinoma who expressed higher MMP-9 levels had shorter survival periods compared to the patients with low MMP-9 expression.
  Key words: Lung Neoplasms; Adenocarcinoma; Matrix Metalloproteinase 9; Prognosis
  Read full text in PDF [Full Text]
Next article

Previous article

Table of contents

Browse all Volumes

Search all Volumes
By keywords
By authors

  Search AoO for:

  Related articles in AoO:
About Journal | Editorial Board | Editorial Policy | Instructions for Authors | Open Access | Advertising | Payed issues | Article Submission Charge | Contact
Founder, owner and publisher: Oncology Institute of Vojvodina, Serbia
Online since 1997 (Abstracts only); 2000 (Abstracts and Full text)
ISSN: 0354-7310 eISSN: 1450-9520